From a case-control survey to a diagnostic viral gastroenteritis panel for testing of general practitioners' patients.

Autor: Bruijnesteijn van Coppenraet LES; Laboratory of Medical Microbiology and Infectious Diseases, Isala, Zwolle, The Netherlands., Flipse J; Laboratory of Medical Microbiology and Infectious Diseases, Isala, Zwolle, The Netherlands., Wallinga JA; Laboratory of Medical Microbiology and Infectious Diseases, Isala, Zwolle, The Netherlands., Vermeer M; ZGT Academy, Ziekenhuisgroep Twente, Almelo, The Netherlands., van der Reijden WA; Regional Laboratory for Medical Microbiology and Public Health Kennemerland, Haarlem, The Netherlands., Weel JFL; Izore, Center for Infectious Diseases Friesland, Leeuwarden, The Netherlands., van der Zanden AGM; Laboratory for Medical Microbiology and Public Health Labmicta, Enschede, The Netherlands., Schuurs TA; Izore, Center for Infectious Diseases Friesland, Leeuwarden, The Netherlands., Ruijs GJHM; Laboratory of Medical Microbiology and Infectious Diseases, Isala, Zwolle, The Netherlands.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2021 Nov 03; Vol. 16 (11), pp. e0258680. Date of Electronic Publication: 2021 Nov 03 (Print Publication: 2021).
DOI: 10.1371/journal.pone.0258680
Abstrakt: Objective: To evaluate the pathogenicity of a broad range of 11 possible gastroenteritis viruses, by means of statistical relationships with cases vs. controls, or Ct-values, in order to establish the most appropriate diagnostic panel for our general practitioner (GP) patients in the Netherlands (2010-2012).
Methods: Archived stool samples from 1340 cases and 1100 controls were retested using internally controlled multiplex real-time PCRs for putative pathogenic gastroenteritis viruses: adenovirus, astrovirus, bocavirus, enterovirus, norovirus GI and GII, human parechovirus, rotavirus, salivirus, sapovirus, and torovirus.
Results: The prevalence of any virus in symptomatic cases and asymptomatic controls was 16.6% (223/1340) and 10.2% (112/1100), respectively. Prevalence of astrovirus (adjusted odds ratio (aOR) 10.37; 95% confidence interval (CI) 1.34-80.06) and norovirus GII (aOR 3.10; CI 1.62-5.92) was significantly higher in cases versus controls. Rotavirus was encountered only in cases. We did not find torovirus and there was no statistically significant relationship with cases for salivirus (aOR 1,67; (CI) 0.43-6.54)), adenovirus non-group F (aOR 1.20; CI 0.75-1.91), bocavirus (aOR 0.85; CI 0.05-13.64), enterovirus (aOR 0.83; CI 0.50-1.37), human parechovirus (aOR 1.61; CI 0.54-4.77) and sapovirus (aOR 1.15; CI 0.67-1.98). Though adenovirus group F (aOR 6.37; CI 0.80-50.92) and norovirus GI (aOR 2.22, CI: 0.79-6.23) are known enteropathogenic viruses and were more prevalent in cases than in controls, this did not reach significance in this study. The Ct value did not discriminate between carriage and disease in PCR-positive subjects.
Conclusions: In our population, diagnostic gastroenteritis tests should screen for adenovirus group F, astrovirus, noroviruses GI and GII, and rotavirus. Case-control studies as ours are lacking and should also be carried out in populations from other epidemiological backgrounds.
Competing Interests: The authors have declared that no competing interests exist.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje